Later developments: Molecular keys to age-related memory impairment

Alzheimer Disease and Associated Disorders

Volumn 17, Issue 3, 2003, Pages 168-176

  Barad, Mark ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 3506 Gonda Building ^*  (United States)

Author keywords

After hyperpolarization; Extinction; L type voltage gated calcium channels; Learning; LTP; Nootropic; Phosphodiesterase

Indexed keywords

CALCIUM CHANNEL L TYPE; CYCLIC AMP; PHOSPHODIESTERASE IV; ROLIPRAM;

AGE; CONFERENCE PAPER; ENZYME INHIBITION; HIPPOCAMPUS; HUMAN; LONG TERM MEMORY; LONG TERM POTENTIATION; MEMORY DISORDER; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AGED; AGING; CALCIUM CHANNELS; CYCLIC AMP; EXTINCTION, PSYCHOLOGICAL; HUMANS; LEARNING; MEMORY DISORDERS; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM;

EID: 0141817996     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200307000-00009     Document Type: Conference Paper

References (139)

1. Small GW. What we need to know about age related memory loss. Br Med J. 2002;324:1502-1505.
2. Small SA, Stern Y, Tang M, et al. Selective decline in memory function among healthy elderly. Neurology. 1999;52:1392-1396.
3. Sanes JR, Lichtman JW. Can molecules explain long-term potentiation? Nat Neurosci. 1999;2:597-604.
4. Emre M, Qizilbash N. Experimental approaches and drugs in development for the treatment of dementia. Expert Opin Invest Drugs. 2001;10:607-617.
5. Tang YP, Shimizu E, Dube GR, et al. Genetic enhancement of learning and memory in mice [see comments]. Nature. 1999;401:63-69.
6. Lynch G. Memory and the brain: unexpected chemistries and a new pharmacology. Neurobiol Learn Mem. 1998;70:82-100.
7. Sugimoto H, Yamanishi Y, Iimura Y, et al. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Curr Med Chem. 2000;7:303-339.
8. Guarraci FA, Frohardt RJ, Kapp BS. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res. 1999;827:28-40.
9. Bach ME, Barad M, Son H, et al. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci USA. 1999;96:5280-5285.
10. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11:398-411.
11. Rose MR. Evolutionary Biology of Aging. New York: Oxford University; 1991.
12. Martin GM. Gene action in the aging brain: an evolutionary biological perspective. Neurobiol Aging. 2002;23:647.
13. Brunelli M, Castellucci V, Kandel ER. Synaptic facilitation and behavioral sensitization in Aplysia: possible role of serotonin and cyclic AMP. Science. 1976;194:1178-1181.
14. Kandel ER, Brunelli M, Byme J, et al. A common presynaptic locus for the synaptic changes underlying short-term habituation and sensitization of the gill-withdrawal reflex in Aplysia. Cold Spring Harb Symp Quant Biol. 1976;40:465-482.
15. Shimahara T, Tauc L. The role of cyclic AMP in the modulation of synaptic efficacy. J Physiol. 1978;74:515-519.
16. Klein M, Kandel ER. Mechanism of calcium current modulation underlying presynaptic facilitation and behavioral sensitization in Aplysia. Proc Natl Acad Sci USA. 1980;77:6912-6916.
17. Castellucci VF, Nairn A, Greengard P, et al. Inhibitor of adenosine 3′:5′-monophosphate-dependent protein kinase blocks presynaptic facilitation in Aplysia. J Neurosci. 1982;2:1673-1681.
18. Goelet P, Castellucci VF, Schacher S, et al. The long and the short of long-term memory: a molecular framework. Nature. 1986;322:419-422.
19. Montarolo PG, Goelet P, Castellucci VF, et al. A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science. 1986;234:1249-1254.
20. Sweatt JD, Kandel ER. Persistent and transcriptionally-dependent increase in protein phosphorylation in long-term facilitation of Aplysia sensory neurons. Nature. 1989;339:51-54.
21. Schacher S, Castellucci VF, Kandel ER. cAMP evokes long-term facilitation in Aplysia sensory neurons that requires new protein synthesis. Science. 1988;240:1667-1669.
22. Dash PK, Hochner B, Kandel ER. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature. 1990;345:718-721.
23. Quinn WG, Harris WA, Benzer S. Conditioned behavior in Drosophila melanogaster. Proc Natl Acad Sci USA. 1974;71:708-712.
24. Kauvar LM. Defective cyclic adenosine 3′:5′-monophosphate phosphodiesterase in the Drosophila memory mutant dunce. J Neurosci. 1982;2:1347-1358.
25. Shotwell SL. Cyclic adenosine 3′:5′-monophosphate phosphodiesterase and its role in learning in Drosophila. J Neurosci. 1983;3:739-747.
26. Duerr JS, Quinn WG. Three Drosophila mutations that block associative learning also affect habituation and sensitization. Proc Natl Acad Sci USA. 1982;79:3646-3650.
27. Dudai Y, Uzzan A, Zvi S. Abnormal activity of adenylate cyclase in the Drosophila memory mutant rutabaga. Neurosci Lett. 1983;42:207-212.
28. Dudai Y, Jan YN, Byers D, et al. dunce, a mutant of Drosophila deficient in learning. Proc Natl Acad Sci USA. 1976;73:1684-1688.
29. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232:331-356.
30. Alger BE, Teyler TJ. Long-term and short-term plasticity in the CA1, CA3, and dentate regions of the rat hippocampal slice. Brain Res. 1976;110:463-480.
31. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry. 1957;20:11-21.
32. Squire LR, Zola SM. Memory, memory impairment, and the medial temporal lobe. Cold Spring Harbor Symp Quant Biol. 1996;61:185-195.
33. Collingridge GL, Kehl SJ, McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol. 1983;334:33-46.
34. Malinow R, Madison DV, Tsien RW. Persistent protein kinase activity underlying long-term potentiation. Nature. 1988;335:820-824.
35. Harris EW, Cotman CW. Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett. 1986;70:132-137.
36. Hopkins WF, Johnston D. Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. J Neurophysiol. 1988;59:667-687.
37. Weisskopf MG, Castillo PE, Zalutsky RA, et al. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science. 1994;265:1878-1882.
38. Huang YY, Li XC, Kandel ER. cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell. 1994;79:69-79.
39. Reymann KG, Malisch R, Schulzeck K, et al. The duration of long-term potentiation in the CA1 region of the hippocampal slice preparation. Brain Res Bull. 1985;15:249-255.
40. Frey U, Krug M, Brodemann R, et al. Long-term potentiation induced in dendrites separated from rat's CA1 pyramidal somata does not establish a late phase. Neurosci Lett. 1989;97:135-139.
41. Frey U, Krug M, Reymann KG, et al. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res. 1988;452:57-65.
42. Matthies H, Reymann KG. Protein kinase A inhibitors prevent the maintenance of hippocampal long-term potentiation. Neuroreport. 1993;4:712-714.
43. Frey U, Huang YY, Kandel ER. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science. 1993;260:1661-1664.
44. Abel T, Nguyen PV, Barad M, et al. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 1997;88:615-626.
45. Barad M, Bourtchouladze R, Winder DG, et al. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci USA. 1998;95:15020-15025.
46. Uttl B, Graf P. Episodic spatial memory in adulthood. Psychol Aging. 1993;8:257-273.
47. Perlmutter M, Metzger R, Nezworski T, et al. Spatial and temporal memory in 20 to 60 year olds. J Gerontol. 1981;36:59-65.
48. Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol. 1979;93:74-104.
49. Bartus RT, Dean RL, Goas JA, et al. Age-related changes in passive avoidance retention: modulation with dietary choline. Science. 1980;209:301-303.
50. Gallagher M, Pelleymounter MA. Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol Aging. 1988;9:549-556.
51. Hersi AI, Rowe W, Gaudreau P, et al. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience. 1995;69:1067-1074.
52. Rapp PR, Amaral DG. Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci. 1992;15:340-345.
53. Baxter MG, Gallagher M. Neurobiological substrates of behavioral decline: models and data analytic strategies for individual differences in aging. Neurobiol Aging. 1996;17:491-495.
54. Deupree DL, Bradley J, Turner DA. Age-related alterations in potentiation in the CA1 region in F344 rats. Neurobiol Aging. 1993;14:249-258.
55. Geinisman Y, Detoledo-Morrell L, Morrell F, et al. Hippocampal markers of age-related memory dysfunction: behavioral, electrophysiological and morphological perspectives. Prog Neurobiol. 1995;45:223-252.
56. Gallagher M, Rapp PR. The use of animal models to study the effects of aging on cognition. Annu Rev Psychol. 1997;48:339-370.
57. Gallagher M, Landfield PW, McEwen B, et al. Hippocampal neurodegeneration in aging [letter]. Science. 1996;274:484-485.
58. Barnes CA. Aging and the physiology of spatial memory. Neurobiol Aging. 1988;9:563-568.
59. de Toledo-Morrell L, Geinisman Y, Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: relation to memory disorders. Neurobiol Aging. 1988;9:581-590.
60. Markowska AL, Stone WS, Ingram DK, et al. Individual differences in aging: behavioral and neurobiological correlates. Neurobiol Aging. 1989;10:31-43.
61. Barnes CA. Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci. 1994;17:13-18.
62. Diana G, Domenici MR, Scotti de Carolis A, et al. Reduced hippocampal CA1 Ca(2+)-induced long-term potentiation is associated with age-dependent impairment of spatial learning. Brain Res. 1995;686:107-110.
63. Hori N, Hirotsu I, Davis PJ, et al. Long-term potentiation is lost in aged rats but preserved by calorie restriction. Neuroreport. 1992;3:1085-1088.
64. Zimmerman ID, Berg AP. An effect of age on the phosphodiesterase activator protein of rat cerebral cortex: a brief note. Mech Ageing Dev. 1977;6:67-71.
65. Berg A, Zimmerman ID. Effects of electrical stimulation and norepinephrine on cyclic-AMP levels in the cerebral cortex of the aging rat. Mech Ageing Dev. 1975;4:377-383.
66. Zimmerman ID, Berg AP. Phosphodiesterase and adenyl-cyclase activities in the cerebral cortex of the aging rat. Mech Ageing Dev. 1975;4:89-96.
67. Araki T, Kato H, Shuto K, et al. Age-related changes in [3H]nimodipine and [3H]rolipram binding in the rat brain. J Pharm Pharmacol. 1997;49:310-314.
68. Catterall WA. Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium. 1998;24:307-323.
69. Westenbroek RE, Ahlijanian MK, Catterall WA. Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons. Nature. 1990;347:281-284.
70. Hell JW, Westenbroek RE, Warner C, et al. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol. 1993;123:949-962.
71. Bading H, Ginty DD, Greenberg ME. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science. 1993;260:181-186.
72. Hardingham GE, Cruzalegui FH, Chawla S, et al. Mechanisms controlling gene expression by nuclear calcium signals. Cell Calcium. 1998;23:131-134.
73. Landfield PW, Lynch G. Impaired monosynaptic potentiation in in vitro hippocampal slices from aged, memory-deficient rats. J Gerontol. 1977;32:523-533.
74. Landfield PW, McGaugh JL, Lynch G. Impaired synaptic potentiation processes in the hippocampus of aged, memory-deficient rats. Brain Res. 1978;150:85-101.
75. Landfield PW, Pitler TA. Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science. 1984;226:1089-1092.
76. Disterhoft JF, Thompson LT, Moyer JR Jr, et al. Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci. 1996;59:413-420.
77. Thibault O, Mazzanti ML, Blalock EM, et al. Single-channel and whole-cell studies of calcium currents in young and aged rat hippocampal slice neurons. J Neurosci Methods. 1995;59:77-83.
78. Landfield PW. Aging-related increase in hippocampal calcium channels. Life Sci. 1996;59:399-404.
79. Thibault O, Landfield PW. Increase in single L-type calcium channels in hippocampal neurons during aging. Science. 1996;272:1017-1020.
80. Thibault O, Hadley R, Landfield PW. Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci. 2001;21:9744-9756.
81. Grover LM, Teyler TJ. Two components of long-term potentiation induced by different patterns of afferent activation. Nature. 1990;347:477-479.
82. Aniksztejn L, Ben-Ari Y. Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature. 1991;349:67-69.
83. Huber KM, Mauk MD, Kelly PT. Distinct LTP induction mechanisms: contribution of NMDA receptors and voltage-dependent calcium channels. J Neurophysiol. 1995;73:270-279.
84. Weisskopf MG, Bauer EP, LeDoux JE. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J Neurosci. 1999;19:10512-10519.
85. Magee JC, Johnston D. A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. Science. 1997;275:209-213.
86. Foster TC. Involvement of hippocampal synaptic plasticity in age-related memory decline. Brain Res Rev. 1999;30:236-249.
87. Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist. 2002;8:297-301.
88. Wittenberg G, Tsien J. An emerging molecular and cellular framework for memory processing by the hippocampus. Trends Neurosci. 2002;25:501.
89. Shors TJ, Matzel LD. Long-term potentiation: what's learning got to do with it? Behav Brain Sci. 1997;20:597-614; discussion 14-55.
90. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci. 1999;22:561-567.
91. Huang EP, Stevens CF. The matter of mind: molecular control of memory. Essays Biochem. 1998;33:165-178.
92. Deyo RA, Nix DA, Parker TW. Nifedipine blocks retention of a visual discrimination task in chicks. Behav Neural Biol. 1992;57:260-262.
93. Nikolaev E, Kaczmarek L. Disruption of two-way active avoidance behavior produced by nimodipine. Pharmacol Biochem Behav. 1994;47:757-759.
94. Borroni AM, Fichtenholtz H, Woodside BL, et al. Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory. J Neurosci. 2000;20:9272-9276.
95. Bauer EP, Schafe GE, LeDoux JE. NMDA receptors and L-type voltagegated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci. 2002;22:5239-5249.
96. Cain CK, Blouin AM, Barad M. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci. 2002;22:9113-9121.
97. Hoffmeister F, Benz U, Heise A, et al. Behavioral effects of nimodipine in animals. Arzneimittelforschung. 1982;32:347-360.
98. Zupan G, Mrsic J, Simonic A. Effects of nicardipine, felodipine and nifedipine on passive avoidance behavior of intact and hypoxia-exposed rats. Arch Int Pharmacodyn Ther. 1993;325:61-69.
99. Clincke GH, Wauquier A. Pharmacological protection against hypoxia-induced effects on medium-term memory in a two-way avoidance paradigm. Behav Brain Res. 1984;14:139-142.
100. Nomura M. Effect of nimodipine on brightness discrimination learning test in Wistar Kyoto and spontaneously hypertensive rats. Arzneimittelforschung. 1988;38:1282-1286.
101. Meneses A, Terron JA, Ibarra M, et al. Effects of nimodipine on learning in normotensive and spontaneously hypertensive rats. Behav Brain Res. 1997;85:121-125.
102. Isaacson RL, Johnston JE, Vargas DM. The effect of a calcium antagonist on the retention of simple associational learning. Physiol Behav. 1988;42:447-452.
103. Tazi A, Farh M, Hakkou F. Behavioral effects of a calcium channel antagonist: nifedipine. Fundam Clin Pharmacol. 1991;5:229-236.
104. Sansone M, Battaglia M, Vetulani J. Shuttle-box avoidance behavior of mice treated with nifedipine in combination with nicotine or physostigmine. Pol J Pharmacol. 1994;46:169-173.
105. Quevedo J, Vianna M, Daroit D, et al. L-type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus. Neurobiol Learn Mem. 1998;69:320-325.
106. Deyo R, Panksepp J, Conner RL. Nimodipine alters acquisition of a visual discrimination task in chicks. Behav Neural Biol. 1990;53:149-152.
107. Levy A, Kong RM, Stillman MJ, et al. Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats. Pharmacol Biochem Behav. 1991;39:781-786.
108. Brooks SP, Hennebry G, McAlpin GP, et al. Nimodipine prevents the effects of ethanol in tests of memory. Neuropharmacology. 2002;42:577-585.
109. McMonagle-Strucko K, Fanelli RJ. Enhanced acquisition of reversal training in a spatial learning task in rats treated with chronic nimodipine. Pharmacol Biochem Behav. 1993;44:827-835.
110. Vetulani J, Battaglia M, Castellano C, et al. Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine. Psychopharmacology. 1993;113:217-221.
111. Quartermain D, Hawxhurst A, Ermita B, et al. Effect of the calcium channel blocker amlodipine on memory in mice. Behav Neural Biol. 1993;60:211-219.
112. Vetulani J, Battaglia M, Sansone M. Nimodipine on shuttle-box avoidance learning in mice: no impairment but slight improvement. Pharmacol Biochem Behav. 1997;56:577-581.
113. Quartermain D. Chronic administration of the Ca(2+) channel blocker amlodipine facilitates learning and memory in mice. Eur J Pharmacol. 2000;399:57-63.
114. Quartermain D, Garcia deSoria V. The effects of calcium channel antagonists on short- and long-term retention in mice using spontaneous alternation behavior. Neurobiol Learn Mem. 2001;76:117-124.
115. Quartermain D, deSoria VG, Kwan A. Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice. Neurobiol Learn Mem. 2001;75:77-90.
116. Popik P, Mamczarz J, Vetulani J. The effect of electroconvulsive shock and nifedipine on spatial learning and memory in rats. Biol Psychiatry. 1994;35:864-869.
117. Lazarova-Bakarova MB, Stancheva S, Petkova B, et al. Effects of beta-adrenoceptor blocker pindolol, calcium antagonist verapamil and their combination on retention in step-down- and shuttle-box-trained rats and on brain biogenic monoamines. J Physiol Paris. 1997;91:301-305.
118. Norman G, Brooks SP, Hennebry GM, et al. Nimodipine prevents scopolamine-induced impairments in object recognition. J Psychopharmacol. 2002;16:153-161.
119. Deyo RA, Straube KT, Disterhoft JF. Nimodipine facilitates associative learning in aging rabbits. Science. 1989;243:809-811.
120. Thompson LT, Deyo RA, Disterhoft JF. Nimodipine enhances spontaneous activity of hippocampal pyramidal neurons in aging rabbits at a dose that facilitates associative learning. Brain Res. 1990;535:119-130.
121. Fanelli RJ, McCarthy RT, Chisholm J. Neuropharmacology of nimodipine: from single channels to behavior. Ann NY Acad Sci. 1994;747:336-350.
122. Kowalska M, Disterhoft JF. Relation of nimodipine dose and serum concentration to learning enhancement in aging rabbits. Exp Neurol. 1994;127:159-166.
123. Solomon PR, Wood MS, Groccia-Ellison ME, et al. Nimodipine facilitates retention of the classically conditioned nictitating membrane response in aged rabbits over long retention intervals. Neurobiol Aging. 1995;16:791-796.
124. Woodruff-Pak DS, Chi J, Li YT, et al. Nimodipine ameliorates impaired eyeblink classical conditioning in older rabbits in the long-delay paradigm. Neurobiol Aging. 1997;18:641-649.
125. Ingram DK, Joseph JA, Spangler EL, et al. Chronic nimodipine treatment in aged rats: analysis of motor and cognitive effects and muscarinic-induced striatal dopamine release. Neurobiol Aging. 1994;15:55-61.
126. Levere TE, Walker A. Old age and cognition: enhancement of recent memory in aged rats by the calcium channel blocker nimodipine. Neurobiol Aging. 1992;13:63-66.
127. Batuecas A, Pereira R, Centeno C, et al. Effects of chronic nimodipine on working memory of old rats in relation to defects in synaptosomal calcium homeostasis. Eur J Pharmacol. 1998;350:141-150.
128. Sandin M, Jasmin S, Levere TE. Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine. Neurobiol Aging. 1990;11:573-575.
129. Ban TA, Morey L, Aguglia E, et al. Nimodipine in the treatment of old age dementias. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:525-551.
130. Skinner MH, Futterman A, Morrissette D, et al. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med. 1992;116:615-623.
131. Parnetti L, Senin U, Carosi M, et al. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group. Clin Ther. 1993;15:394-406.
132. Leonetti G, Salvetti A. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study. J Cardiovasc Pharmacol. 1994;24(suppl):73-77.
133. Sze KH, Sim TC, Wong E, et al. Effect of nimodipine on memory after cerebral infarction. Acta Neurol Scand. 1998;97:386-392.
134. Rossi R, Inzitari D, Pantoni L, et al. Nimodipine in subcortical vascular dementia trial. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):159-165.
135. Pantoni L, Rossi R, Inzitari D, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000a;175:124-134.
136. Pantoni L, Bianchi C, Beneke M, et al. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia. J Neurol Sci. 2000b;175:116-123.
137. Lopez-Arrieta JM, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev. 2002;3:CD000147.
138. Bouton ME, King DA. Contextual control of the extinction of conditioned fear: tests for the associative value of the context. J Exp Psychol Anim Behav Process. 1983;9:248-265.
139. Bouton ME, Bolles RC. Contextual control of the extinction of conditioned fear. Learning Motivation. 1979;10:445-466.